Previous Close | 238.03 |
1-Year Change | 65.66% |
6-Months Change | 23.73% |
3-Months Change | 11.61% |
Moving Avg (50d) | 224.19 |
Moving Avg (200d) | 198.43 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 35.0B |
Beta (3-Years) | 0.89 |
Revenue Growth (ttm) | 20.71% |
Net Profit Margin (ttm) | 20.72% |
Return On Assets (ttm) | 13.45% |
EPS (ttm) | 6.16 |
PE Ratio (ttm) | 38.64 |
Dividend Yield | 0.76% |
Asset Description: | ResMed Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
233.269 | 226.128 | 221.368 | 214.227 | 202.325 | 190.424 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.